Verition Fund Management LLC Invitae Corp Transaction History

Verition Fund Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $281,007 - $639,292	234,173 New	234,173 $316,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $3,230 - $14,671	-1,700 Reduced 12.89%	11,489 $28,000
Q2 2022 Aug 15, 2022	SELL	$2.13 - $9.01 $22,356 - $94,568	-10,496 Reduced 44.31%	13,189 $32,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $148,741 - $369,249	23,685 New	23,685 $189,000
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $1.53 Million - $2.37 Million	-58,748 Closed	0 $0

Q1 2021 May 18, 2021	BUY	$33.06 - $56.93 $1.59 Million - $2.75 Million	48,240 Added 459.08%	58,748 $2.24 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $89,164 - $130,929	2,281 Added 27.73%	10,508 $439,000
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $233,893 - $367,500	8,227 New	8,227 $357,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.